Gencove
Gencove is a New York-based genomics technology company offering low-pass whole genome sequencing with proprietary imputation to pharmaceutical, academic, agricultural, and consumer customers via an enterprise platform and a $69 DTC test kit.
- Company typePrivate
- Founded2015
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Gencove does
Gencove is a New York-based genomics technology company founded in 2015 that commercializes low-pass whole genome sequencing (lpWGS) — a method that reads the entire genome at approximately 0.5x coverage and uses a proprietary imputation pipeline, calibrated against large reference panels and tuned for accuracy across diverse ancestries, to infer millions of additional variants at >99% concordance with microarray genotyping for common variants. The company operates a dual-track business: a direct-to-consumer product (Gencove Consumer, launched March 2026, $69 per kit) delivering PRS-based health risk reports across nine traits, ancestry analysis, and raw data download; and an enterprise platform (Gencove Enterprise / Base / Explorer) serving pharmaceutical companies, biobanks, academic institutions, and agricultural genomics customers with population-scale sequencing workflows, a JupyterLab-based analysis cloud, a Python CLI/SDK, and a REST API with multi-region deployment.
The enterprise platform generates revenue through subscription/recurring platform services and project-based sequencing contracts with named customers including GSK, Boehringer Ingelheim, Stanford University, the University of Oxford, the USDA, Syngenta, Neogen, BGI, Element Biosciences, Ultima Genomics, Gene by Gene, and the Weizmann Institute. The consumer channel operates as a one-time e-commerce transaction priced at $69 per kit, with US-only shipping as of the disclosure date and international expansion publicly signaled. The company has raised approximately $16.15M across five funding rounds through 2021 (latest: $10M Series A led by Lewis & Clark AgriFood), holds 11–50 employees per the disclosed band, and is led by CEO Joe Pickrell and CTO/Co-founder Tomaz Berisa. Technical differentiators include imputation optimized for diverse ancestries, raw data ownership for customers (enabling reanalysis as science evolves), CLIA-certified laboratory processing, and EU-U.S./UK/Swiss Data Privacy Framework certifications supporting international data handling.
Gencove firmographics
Firmographics- Name
- Gencove
- Legal name
- Gencove, Inc.
- Website
- https://gencove.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Gencove is a New York-based genomics technology company offering low-pass whole genome sequencing with proprietary imputation to pharmaceutical, academic, agricultural, and consumer customers via an enterprise platform and a $69 DTC test kit.
- Ownership category
- akta.pro rank
Gencove industry classification
Industry- Product category
- Genomic Sequencing & Analytics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Genomic Testing & Genetic Evaluation Services (AFAEAJAC), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Population Genomics & Preventive Precision Health Programs (HLAAANAL)
Keywords
Where Gencove is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Gencove business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Consumer DNA Testing Kits: Direct-to-consumer sales of at-home DNA collection kits at $69 per kit. Includes buccal swab collection, low-pass whole genome sequencing, polygenic risk score reports across 7+ health traits, ancestry analysis, and raw data download.
- Enterprise Genomic Platform: B2B platform services for research institutions, biobanks, and pharmaceutical companies including assay development, sequencing, and data analytics & management solutions for population-scale genomics research.
- Technology Partnership - Twist Bioscience: Collaboration with Twist Bioscience for the FlexPrep Ultra-High Throughput Library Preparation Kit for agrigenomics and population genomics applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | $69 consumer DNA test kit |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Gencove product offering
Product offeringCore offering
Gencove sells low-pass whole genome sequencing (lpWGS) and imputation-based genomic analysis through two distinct channels: a direct-to-consumer $69 at-home DNA testing kit with Polygenic Risk Score reports across 8+ health traits and ancestry analysis, and an enterprise cloud platform (Gencove Base + Explorer) providing population-scale genomic sequencing, imputation, project/sample management, and analytical shortcuts for research institutions, biobanks, pharmaceutical companies, and agrigenomics customers. Both channels share the same proprietary lpWGS and imputation technology stack.
Product overview
Gencove operates as a genomics technology company offering a dual-track product portfolio. For consumers (Gencove Consumer), it provides at-home DNA testing using low-pass whole genome sequencing (lpWGS), delivering PRS-based health risk reports, ancestry analysis, and raw genomic data downloads for $69. For research and enterprise customers (Gencove Enterprise/Base), it provides a cloud-based sequencing analytics platform comprising Gencove Base (project/sample management via web dashboard, REST API, and CLI), Gencove Explorer (JupyterLab-based analysis cloud with shortcut library for VCF management, relatedness, and IGV), and the Gencove CLI (Python SDK). Both tracks share the same core lpWGS technology and imputation pipeline, with the consumer product packaging enterprise-grade genomic infrastructure into an accessible consumer offering.
Differentiator
Problem solved
Functional benefit
Brands
- Gencove Enterprise Platform: Low-pass sequencing and imputation workflows for research institutions, biobanks, and pharmaceutical companies
- Gencove Explorer
- Gencove Base
- Gencove Consumer
Products and services
- Gencove Consumer DNA Test Kit
- Gencove Enterprise Platform
Quantifiable outcome
- >99% concordance with microarray genotyping for common variants (minor allele frequency >5%)
Companies that use Gencove
Customer profileNamed customers13 records
Segments4 records
Ideal customer profiles4 records
Gencove technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability2 records
Feature5 records
Gencove partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Twist BiosciencecoreTwist Bioscience launched the FlexPrep Ultra-High Throughput Library Preparation Kit designed for high-volume applications in agrigenomics and population genomics, collaborating with Gencove to enhance genomic analysis solutions. The kit offers significant cost and time savings by automating normalization and multiplexing processes, allowing up to 1,152 samples per run. The collaboration aims to accelerate adoption of next-generation sequencing (NGS) in large-scale genomic research.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Gencove competitors and assessment
Company assessmentBroad incumbents
- Element Biosciences: Element Biosciences is a sequencing instrument manufacturer whose AVITI system is positioned as a lower-cost alternative to Illumina. It is listed as a Gencove trusted partner and represents adjacent sequencing infrastructure that competes with and complements Gencove's platform.
- Ultima Genomics: Ultima Genomics is a sequencing instrument company developing high-throughput, low-cost NGS platforms. Gencove is listed as a trusted partner with Ultima integration (October 2025), making Ultima both an infrastructure partner and adjacent player in low-cost sequencing.
- BGI: BGI is a global genomics organization with sequencing services, instrument manufacturing (MGI), and large-scale population genomics programs. It is a listed Gencove partner and broader incumbent in genomics services with significantly greater scale and geographic reach.
Direct peers
- 23andMe: 23andMe is the largest direct-to-consumer genetic testing company, offering saliva-based DNA tests for ancestry and health traits. It is the most direct competitor to Gencove's $69 consumer kit, though 23andMe uses microarray genotyping rather than low-pass whole genome sequencing.
- Ancestry (AncestryDNA): AncestryDNA is a major consumer genetic testing service focused primarily on ancestry and family history, with microarray-based genotyping. It competes directly with Gencove Consumer in the DTC market and has a substantially larger customer base and brand recognition.
- Dante Labs: Dante Labs is a direct-to-consumer whole genome sequencing provider offering 30x WGS and whole exome sequencing to consumers internationally. It is a direct competitor to Gencove Consumer in the WGS-based DTC testing category, with broader international availability.
- Nebula Genomics: Nebula Genomics offers direct-to-consumer whole genome sequencing with an emphasis on data privacy and ownership. It uses 30x whole genome sequencing rather than Gencove's low-pass approach, but competes for the same privacy-conscious, data-owning consumer seeking comprehensive genomic data.
Others
- Twist Bioscience: Twist Bioscience is a synthetic biology and DNA synthesis company that partnered with Gencove on the FlexPrep Ultra-High Throughput Library Preparation Kit (October 2024). It is a key ecosystem partner enabling Gencove's agrigenomics throughput rather than a direct competitor.
Emerging players
- Helix: Helix operates a sequencing-as-a-service platform serving health systems, population health programs, and consumer applications. It competes with Gencove Enterprise in population-scale genomic analysis and offers its own consumer-facing products through partners.
- Color Health: Color Health provides genetic testing with a focus on clinical-grade health screening, population health programs, and enterprise health benefits. It overlaps with Gencove in genetic testing and population genomics but emphasizes clinical utility rather than raw data ownership or sequencing methodology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Gencove social profiles
Digital presenceGencove compliance and trust
Trust signalCompliance4 records
Gencove financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gencove leadership team
Management profileNumber of profiles
Profiles3 records
Gencove funding detail
Funding detailFunding overview
Funding rounds5 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gencove M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gencove
What does Gencove do?
Gencove sells low-pass whole genome sequencing (lpWGS) and imputation-based genomic analysis through two distinct channels: a direct-to-consumer $69 at-home DNA testing kit with Polygenic Risk Score reports across 8+ health traits and ancestry analysis, and an enterprise cloud platform (Gencove Base + Explorer) providing population-scale genomic sequencing, imputation, project/sample management, and analytical shortcuts for research institutions, biobanks, pharmaceutical companies, and agrigenomics customers. Both channels share the same proprietary lpWGS and imputation technology stack.
Is Gencove a public or private company?
Gencove is a private company. It is classified as venture growth investor backed and is currently operating.
When was Gencove founded?
Gencove was founded in 2015. It employs 11 to 50 people.
Where is Gencove based?
Gencove is headquartered in New York, United States, in the North America region.
How does Gencove make money?
Three revenue lines are on record. Consumer DNA Testing Kits are the primary driver. The others are enterprise Genomic Platform and technology Partnership - Twist Bioscience.
Who are Gencove's main competitors?
Broad incumbents on record are Element Biosciences, Ultima Genomics and BGI. Direct peers are 23andMe, Ancestry (AncestryDNA), Dante Labs and Nebula Genomics. Twist Bioscience is listed as an others. Emerging players are Helix and Color Health.
Does Gencove have an API?
Yes. REST API for managing genomic projects, samples, file uploads/downloads, analysis pipelines, and consumer reports. Authentication via API key (Authorization: Api-Key header) or email/password. Multi-environment support (e.g., EU host at api.eu1.gencove.com). The Gencove CLI (Python SDK) exposes these APIs via commands such as gencove upload, gencove explorer, and gencove explorer instances. OAuth support for consumer-facing sign-in (Google, Apple). Variant-level API access announced May 2026 for consumer genetics. MCP (Model Context Protocol) server/integration available for consumer genetics (announced April 2026). CLI is compatible with Python 3.8 and above; source mirrored on GitHub. Developer documentation is at api.gencove.com/api/v2/docs.
What industry is Gencove in?
Gencove's product category is Genomic Sequencing & Analytics. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.